Abstract
Anti-HCV activity of aryl diketoacid (ADK) has been characterized by its two pharmacophoric elements, α,β-diketo acid moiety and substituted aryl ring. In this study, as a part of our ongoing efforts to discover a novel anti-HCV compound mimicking the ADK scaffold, we designed 2- arylmethylaminomethyl-5,6-dihydroxychromone derivatives of which the dihydroxychromone moiety as well as the arylmethylaminomethyl substituent (R-PhCH 2NHCH 2-) were anticipated in exact match with the pharmacophore model of the ADK. The dihydroxychromone derivatives (3a-3u), thus prepared, showed biological activity in a substituent-dependent fashion, thereby leading to selective anti-HCV effect (EC 50 = 2.0-14.0 μM, CC 50 >100 μM) with the substituent groups such as Cl, Br, I, and Me specifically at the 3-position of the aromatic ring.
| Original language | English |
|---|---|
| Pages (from-to) | 3202-3205 |
| Number of pages | 4 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 21 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Jun 2011 |
| Externally published | Yes |
Keywords
- 2-Arylmethylaminomethyl-5,6-dihydroxychromone
- ADK (aryl diketoacid)
- Bioisostere
- Hepatitis C virus (HCV)
Fingerprint
Dive into the research topics of '2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver